What is OneThree Biotech?
OneThree Biotech is a clinically validated, biology-driven artificial intelligence (AI) company. It leverages its proprietary AI platform, combined with systems biology, to decipher the intricate mechanisms that govern drug-target-disease relationships. The company's technology integrates diverse datasets—chemical, biological, and clinical—with advanced computational tools to address complex challenges in disease biology and drug discovery. OneThree Biotech's AI platform has demonstrated efficacy in accelerating early-stage drug discovery and development by rapidly generating novel, testable insights and hypotheses. Its platform's capabilities have been validated through numerous partnerships, clinical trials, and over 20 peer-reviewed publications, highlighting its success in optimizing the drug development pipeline.
How much funding has OneThree Biotech raised?
OneThree Biotech has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2020): $2.5M with participation from Meridian Street Capital and Primary Venture Partners
Key Investors in OneThree Biotech
Meridian Street Capital
Meridian Street Capital is a closely held investment fund looking to partner with entrepreneurs seeking to grow and develop their business.
Primary Venture Partners
Primary Venture Partners is a venture capital firm that invests in early-stage technology companies, focusing on building category-defining businesses.
What's next for OneThree Biotech?
The substantial enterprise-level funding indicates a pivotal growth phase for OneThree Biotech, likely focused on scaling its AI platform's application in drug discovery and potentially expanding its partnership ecosystem. This strategic capital infusion is expected to accelerate the translation of its validated insights into tangible therapeutic advancements, positioning the company for significant impact in the pharmaceutical industry. Future developments may include further clinical validation, broader adoption of its AI solutions by other biotech and pharmaceutical firms, and the progression of its internal drug development pipeline.
See full OneThree Biotech company page
